SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000944809-22-000026
Filing Date
2022-05-09
Accepted
2022-05-09 17:09:28
Documents
87
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q opk-20220331.htm   iXBRL 10-Q 2015825
2 EX-31.1 opk-3312022xex311.htm EX-31.1 9410
3 EX-31.2 opk-3312022xex312.htm EX-31.2 9387
4 EX-32.1 opk-3312022xex321.htm EX-32.1 3688
5 EX-32.2 opk-3312022xex322.htm EX-32.2 3721
  Complete submission text file 0000944809-22-000026.txt   11419905

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opk-20220331.xsd EX-101.SCH 76006
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opk-20220331_cal.xml EX-101.CAL 96272
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opk-20220331_def.xml EX-101.DEF 510911
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opk-20220331_lab.xml EX-101.LAB 965374
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opk-20220331_pre.xml EX-101.PRE 687982
81 EXTRACTED XBRL INSTANCE DOCUMENT opk-20220331_htm.xml XML 2026569
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 22906090
SIC: 2834 Pharmaceutical Preparations